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Research Article

Nephrology

Fibrosis is the common final pathway of virtually all chronic injury to the kidney. While it is
well accepted that myofibroblasts are the scar-producing cells in the kidney, their cellular
origin is still hotly debated. The relative contribution of proximal tubular epithelium and
circulating cells, including mesenchymal stem cells, macrophages, and fibrocytes, to the
myofibroblast pool remains highly controversial. Using inducible genetic fate tracing of
proximal tubular epithelium, we confirm that the proximal tubule does not contribute to the
myofibroblast pool. However, in parabiosis models in which one parabiont is genetically
labeled and the other is unlabeled and undergoes kidney fibrosis, we demonstrate that a
small fraction of genetically labeled renal myofibroblasts derive from the circulation. Singlecell RNA sequencing confirms this finding but indicates that these cells are circulating
monocytes, express few extracellular matrix or other myofibroblast genes, and express
many proinflammatory cytokines. We conclude that this small circulating myofibroblast
progenitor population contributes to renal fibrosis by paracrine rather than direct
mechanisms.
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Fibrosis is the common final pathway of virtually all chronic injury to the kidney. While it is well
accepted that myofibroblasts are the scar-producing cells in the kidney, their cellular origin is
still hotly debated. The relative contribution of proximal tubular epithelium and circulating cells,
including mesenchymal stem cells, macrophages, and fibrocytes, to the myofibroblast pool
remains highly controversial. Using inducible genetic fate tracing of proximal tubular epithelium,
we confirm that the proximal tubule does not contribute to the myofibroblast pool. However, in
parabiosis models in which one parabiont is genetically labeled and the other is unlabeled and
undergoes kidney fibrosis, we demonstrate that a small fraction of genetically labeled renal
myofibroblasts derive from the circulation. Single-cell RNA sequencing confirms this finding
but indicates that these cells are circulating monocytes, express few extracellular matrix or other
myofibroblast genes, and express many proinflammatory cytokines. We conclude that this small
circulating myofibroblast progenitor population contributes to renal fibrosis by paracrine rather
than direct mechanisms.
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Conflict of interest: The authors have
declared that no conflict of interest
exists.
Submitted: January 2, 2018
Accepted: April 4, 2018
Published: May 3, 2018
Reference information:
JCI Insight. 2018;3(9):e99561. https://
doi.org/10.1172/jci.insight.99561.

Chronic kidney disease (CKD) affects 10% of the population of Europe and the United States, and disease
prevalence is increasing steadily. Renal interstitial fibrosis correlates well with kidney functional decline,
and inhibition of fibrosis is a promising strategy to slow down progression of CKD. While it is well accepted that myofibroblasts are the cells that cause fibrosis, the cellular origin of kidney myofibroblasts is still
very controversial (1–3). We have reported that approximately half of all kidney myofibroblasts are derived
from the pericyte lineage (4). However, the origins of the other half remains unclear. A precise definition of
the cellular origins of kidney myofibroblasts represents a key step to understanding fibrosis and developing
therapeutics to slow progression of CKD.
The contribution of proximal tubular epithelium to the myofibroblast pool via epithelial-to-mesenchymal transition has been controversial for almost 20 years and is ongoing (5–9). Genetic fate-tracing
experiments have come to different conclusions, reporting no contribution (9), a major contribution (10), or
a minor contribution of the epithelium (11).
Similarly, the degree to which circulating progenitor cells contribute to the myofibroblast pool has
also been debated for many years (2, 12, 13). Bone marrow–derived mesenchymal stem cells (MSCs)
have been reported to contribute to as much as 35% of the renal myofibroblast pool (11). Furthermore,
fibrocytes and macrophages have also been defined as kidney myofibroblast progenitors. Fibrocytes were
originally described more than two decades ago as a leukocyte-derived population of fibroblast-like cells
in subcutaneously implanted wound chambers that express extracellular matrix proteins, such as collagen
I (14). Regarding a contribution of fibrocytes to the myofibroblast pool in kidney fibrosis, studies from
different groups have led to different conclusions. While bone marrow transplantation experiments using
collagen 1a1 or collagen 1a2 reporter chimeras suggest no significant contribution of circulating bone
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marrow–derived cells to the myofibroblast pool (15, 16), other groups have reported a major contribution
of hematopoietic lineage-derived fibrocytes and macrophages to kidney fibrosis (17–24).
Most studies to date have relied heavily on confocal microscopy and/or bone marrow transplantation experiments. Discriminating myofibroblasts from hematopoietic lineage cells by confocal microscopy is technically challenging due to their thin, branched architecture and to their abundance in the
renal interstitium after injury. Furthermore, bone marrow transplantation experiments using genetic
reporters result in engraftment solely of hematopoietic stem cells, whereas other bone marrow cells,
such as MSCs, do not engraft well (4, 25), precluding analysis of the contribution of MSC lineage cells
to the myofibroblast pool. Using an inducible genetic fate-tracing model, we confirmed that proximal
tubular epithelium does not contribute to the myofibroblast pool. In order to dissect the contribution of
any circulating cells to the renal myofibroblast pool, we have performed parabiosis and single-cell RNA
sequencing (scRNA-seq) experiments. Our data indicate that monocytes contribute a small fraction of
myofibroblasts in kidney fibrosis, whereas most myofibroblasts are derived from resident mesenchymal
cells, such as pericytes and resident fibroblasts.

Results
Inducible genetic fate tracing indicates no contribution of proximal tubular epithelium to the myofibroblast pool in
kidney fibrosis. We recently developed an inducible and proximal tubule–specific Cre driver (26) by knocking
a CreERt2 cassette into the sodium-dependent inorganic phosphate transporter SLC34a1 locus, which is
expressed only in the proximal tubule. In order to perform inducible genetic fate tracing of proximal tubular epithelium, we generated bigenic SLC34a1-GFPCreERt2; tdTomato mice (Figure 1A). Eight-week-old
mice were pulsed with high-dose tamoxifen and subjected to unilateral ureteral obstruction (UUO) surgery
at 10 days after the last tamoxifen dose (Figure 1B). Careful evaluation and quantification of kidney sections costained for α-SMA indicated that proximal tubular epithelial cells do not become interstitial myofibroblasts (Figure 1, C and D).
Parabiosis model with fate tracing of all cells from one mouse and kidney fibrosis induction in the other. To
quantitate and better describe the contribution of circulating cells to the kidney myofibroblast pool,
we performed parabiosis experiments with generalized genetic cell fate tracing in one parabiont and
induction of kidney fibrosis in the other. To ubiquitously genetically label cells with the bright red fluorochrome tdTomato, bigenic Rosa26CreER;tdTomato mice received tamoxifen and underwent parabiosis
surgery at 10 days after the last tamoxifen dose (Figure 2A). The Rosa26CreER;tdTomato mice were
conjoined with B6-CD45.1+ mice, which do not express tdTomato but express a different isoform of the
pan-leukocyte marker CD45, which can be discriminated by flow cytometry (B6-CD45.1+, as opposed to
Rosa26CreER;tdTomato-CD45.2+) (Figure 2A). Shared circulation and recombination efficiency were
verified 4 weeks after parabiosis surgery and before induction of kidney fibrosis (Figure 2, B and C). The
analysis showed a good cross-circulation, indicated by an almost 1:1 ratio of CD45.1+ and CD45.2+ cells
and a recombination efficiency of >90% (Figure 2, B and C). The B6-CD45.1 parabiont was then subjected to UUO surgery to assess whether any circulating tdTomato+ cells from the Rosa26CreER;tdTomato
(CD45.2+) parabiont would contribute to the myofibroblast pool during kidney fibrosis. Mice were sacrificed 10 days after UUO surgery. The contralateral noninjured kidney (CLK) served as an internal control. Development of fibrosis in the UUO model was confirmed by trichrome staining and quantification
(Supplemental Figure 1, A and B; supplemental material available online with this article; https://doi.
org/10.1172/jci.insight.99561DS1). Flow cytometric evaluation of PBS-perfused spleens from CD45.1
mice showed a cross-circulation with CD45.1+ and CD45.2+ leukocytes from both mice and confirmed
efficient recombination (Figure 2, D and E). As expected, UUO surgery resulted in a tremendous influx
of leukocytes into the UUO kidneys. More than half of the leukocytes were derived from the CD45.2
(Rosa26CreER;tdTomato) parabiont (Figure 2, F–H), confirming the effectiveness of the cross-circulation and an optimal experimental set up to study influx of circulating cells from the conjoined mouse.
Representative gating on living, single kidney cells is shown in Supplemental Figure 1C.
Circulating cells contribute to a minor fraction of renal myofibroblasts. We next measured the contribution
of circulating cells (tdTomato+) to the myofibroblast lineage. Half of the fibrotic (UUO) and control
(CLK) kidneys were subjected to flow cytometric evaluation and costaining with the myofibroblast marker
α-smooth muscle actin (α-SMA). Flow cytometric evaluation after gating on single and living (DAPI–) cells
indicated that, indeed, a small fraction of renal myofibroblasts was derived from circulation (tdTomato+/αinsight.jci.org   https://doi.org/10.1172/jci.insight.99561
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Figure 1. Inducible genetic fate tracing indicates no contribution of proximal tubular epithelium to kidney myofibroblasts. (A) Scheme of the
generation of SCL34a1GFPCreERt2; tdTomato mice. (B) Scheme of the genetic fate-tracing experiment; 8-week-old SLC34a1GFPCreER;tdTomato mice
(n = 3 males) were pulsed with tamoxifen (3 × 10 mg p.o.) and subjected to UUO surgery at 10 days after the last tamoxifen dose. Mice were sacrificed
10 days after surgery. (C) Representative images of contralateral noninjured (CLK) and injured (unilateral ureteral obstruction [UUO]) kidneys stained
for α-SMA. Original magnification, ×4 (first and third columns); ×60 (second and fourth columns). (D) Quantification of tdTomato+ and α-SMA+ versus
α-SMA– cells. All data represent mean ± SD.

SMA+) (Figure 3, A–F). While we observed a tremendous increase of both tdTomato+ cells (influx of all
circulating cells) and α-SMA+ cells (expansion of myofibroblasts) after UUO, as expected, only a small fraction of myofibroblasts coexpressed tdTomato, indicating that they originated from the Rosa26CreER;tdTomato parabiont (Figure 3, A–F). Confocal microscopy of the Rosa26CreER;tdTomato (CD45.2) kidney
confirmed the recombination efficiency and showed that all cells were tdTomato+ (Figure 3G).
To confirm the flow cytometric data, we used high-resolution confocal microscopy (Airyscan detector)
to localize tdTomato+ myofibroblasts that were derived from circulation. While we only observed sparse
tdTomato+ cells in the CLK kidneys of the B6-CD45.1 parabiont, high-resolution confocal microscopy
confirmed areas with large numbers of tdTomato+ cells in the UUO kidneys. Importantly, we observed
some tdTomato+ cells that indeed coexpressed perinuclear α-SMA (Figure 3H, arrows in UUO images),
thus confirming the flow cytometric data with high-resolution imaging of renal interstitium.
Flow cytometric analysis revealed that all cells in the UUO kidneys that were derived from circulation (tdTomato+) also coexpressed CD45.2 (Figure 4, A and B) and, thus, were of hematopoietic lineage.
Indeed, costaining for CD45 with subsequent confocal microscopy showed that tdTomato+ cells in the
kidneys showed a thin layer of CD45 membrane staining, confirming their hematopoietic origin (Figure 4,
C and D, insets). We next aimed to identify a combination of surface markers that would allow isolation
of myofibroblasts from circulation in comparison to noncirculating myofibroblasts. As we have previously reported that all renal myofibroblasts coexpress the mesenchymal marker PDGFRβ (4) and PDGFRβ
has also been described as a marker of circulating fibrocytes (27), a combination of PDGFRβ with CD45
insight.jci.org   https://doi.org/10.1172/jci.insight.99561
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Figure 2. Parabiosis with genetic fate tracing to
dissect the contribution of circulating cells to kidney fibrosis. (A) Rosa26CreER;tdTomato mice (n =
8; all females, 8 week of age) received tamoxifen
(4 × 10 mg p.o. every other day) to genetically tag
all cells and were conjoined with B6.SJL (CD45.1)
mice at 10 days after the last tamoxifen dose.
Four weeks after parabiosis surgery the B6.SJL
parabiont was subjected to unilateral ureteral
obstruction (UUO) surgery to induce kidney fibrosis. Mice were sacrificed 10 days after UUO surgery.
n = 2 mice died during the experiment; final data
represent n = 6 parabiosis pairs in all readouts. MF,
myofibroblast. (B) Representative flow cytometric
plot and quantification of CD45.1+ versus CD45.2+
cells in the blood of the B6.SJL (CD45.1) parabiont
at 4 weeks after parabiosis surgery. (C) Representative flow cytometric plot and quantification
of recombination efficiency (i.e., tdTomato+) of
CD45.2+ cells in the blood of the B6.SJL parabiont
at 4 weeks after parabiosis surgery. (D) Representative flow cytometric plots and quantification of
CD45.1+ versus CD45.2+ cells in the spleen of the
B6.SJL (CD45.1) parabiont after sacrifice. (E) Representative flow cytometric plot and quantification
of recombination efficiency (i.e., tdTomato+) of
CD45.2+ cells in the spleen of the B6.SJL parabiont
after sacrifice. (F–H) Representative flow cytometric plots and quantification of CD45.1+ versus
CD45.2+ leukocyte influx into the contralateral
noninjured (CLK) and fibrotic UUO kidneys. All data
represent mean ± SD. **P < 0.01 by unpaired t test;
n = 6 in each graph.

would allow the isolation of circulating hematopoietic myofibroblasts (PDGFRβ+CD45+) and resident
nonhematopoietic (PDGFRβ+CD45–) cells. Indeed, costaining of kidneys for PDGFRβ indicated that the
tdTomato+/α-SMA+ population of myofibroblasts derived from circulation coexpressed PDGFRβ (Figure
3H). Thus, our data suggest that costaining for the pan-leukocyte marker CD45 and the mesenchymal
marker PDGFRβ can be used to isolate both resident and circulating kidney myofibroblasts.
scRNA-seq confirms a contribution of circulating CD45+ cells to the myofibroblast pool. We next turned to
an unbiased nonparabiosis approach to confirm our genetic fate-tracing parabiosis results with scRNAseq from FACS isolated PDGFRβ+CD45+ and PDGFRβ+CD45– cells. C57BL/6 wild-type mice were
subjected to UUO surgery and sacrificed 10 days after surgery. We sorted either myofibroblasts that were
derived from circulation (PDGFRβ+CD45+) or all other myofibroblasts (PDGFRβ+CD45–) as singlets
into individual wells of 96-well plates (Supplemental Figure 2A). We sorted two 96-well plates of each
population from whole digested UUO kidney samples and subjected the samples to scRNA-seq. The
kidney samples were pooled from 3 different mice. Cells from 2 different plates were distributed evenly in the tSNE analysis clusters, excluding batch effects (Supplemental Figure 2B). The tSNE analysis
resulted in 2 distinct clusters that were almost identical; the 2 sorted cell populations were made up of
PDGFRβ+CD45+ and PDGFRβ+CD45– cells (Figure 5A). The top 30 upregulated genes in both clusters
are outlined in Supplemental Figure 2C. Importantly, the scRNA-seq data confirmed the results of the
parabiosis fate-tracing experiment and demonstrated that the great majority of myofibroblasts identified
by expression of α-SMA (Acta2) and or collagen (Col1a1, Col3a1) were among the PDGFRβ+CD45–
population or resident kidney cells, whereas only a few myofibroblasts were among the population of
insight.jci.org   https://doi.org/10.1172/jci.insight.99561
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Figure 3. A small fraction of kidney myofibroblasts is derived from circulation. (A) Flow cytometric plots of myofibroblasts (α-SMA+), circulating cells
(tdTomato+), and α-SMA, tdTomato double-positive cells, i.e., myofibroblasts derived from circulation in noninjured contralateral kidneys (CLK) and
fibrotic — unilateral ureteral obstruction (UUO) — kidneys from B6.SJL (CD45.1) mice (n = 6). (B) Fraction of circulating tdTomato+ cells from all kidney
cells in CLK and fibrotic (UUO) kidneys from B6.SJL (CD45.1) mice (n = 6). (C) Fraction of myofibroblasts (α-SMA+) from all kidney cells in CLK and fibrotic
(UUO) kidneys from B6.SJL (CD45.1) mice (n = 6). (D) Fraction of myofibroblasts derived from circulation (α-SMA+/tdTomato+) from all kidney cells in CLK
and fibrotic (UUO) kidneys from B6.SJL (CD45.1) mice (n = 6). (E and F) Fraction of myofibroblasts derived from circulation (tdTomato+/α-SMA+) from all
α-SMA+ myofibroblasts (n = 6). (G) Representative image of the noninjured kidney of the Rosa26CreER;tdTomato parabiont. Scale bars: 50 μm; 25 μm
(inset). (H) High-resolution confocal microscopy (Airyscan) images of CLK and fibrotic (UUO) kidneys from B6.SJL (CD45.1) mice costained for α-SMA and
PDGFRβ. Large arrows indicate tdTomato+ cells coexpressing α-SMA and PDGFRβ. Small arrows indicate the area of thin membranous PDGFRβ signal.
Scale bars: 50 μm (column 1); 20 μm (columns 2–5); 10 μm (insets). All data represent mean ± SD. *P < 0.05, **P < 0.01, ***P < 0.001 by unpaired t test.

circulating hematopoietic PDGFRβ+CD45+ cells (Figure 5, B–E). The PDGFRβ+CD45– population
showed expression of markers that have been associated with pericytes and myofibroblasts, such as
Timp1, Col1a1, Col3a1, Rgs5, desmin, CSPG4, and the mesenchymal marker vimentin (Figure 5, B–H,
and Supplemental Figure 2C), whereas the population of myofibroblasts derived from circulation (PDGFRβ+CD45+) showed high expression of the monocyte marker CD68 (Figure 5I).
We next examined expression of extracellular matrix proteins as well as chemokines and cytokines
that have been associated with fibrosis. Interestingly the resident PDGFRβ+CD45– population showed
strong expression of various collagens and fibronectin, connective tissue growth factor (CTGF), and
TGF-β3, whereas the circulating population of PDGFRβ+CD45+ cells primarily expressed various
insight.jci.org   https://doi.org/10.1172/jci.insight.99561
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Figure 4. Myofibroblasts derived from circulation coexpress PDGFRβ and CD45. (A and B) Representative flow cytometric plot and quantification of
tdTomato+ and CD45.2+ cells in blood, spleens, and UUO kidneys of the B6.SJL (CD45.1) mice (n = 6). (C) Representative high-resolution confocal microscopy
images of contralateral noninjured kidney (CLK) and fibrotic unilateral ureteral obstruction (UUO) kidneys from B6.SJL (CD45.1) mice costained for α-SMA
and CD45. Large arrows indicate tdTomato+ cells coexpressing α-SMA and CD45. Small arrows indicate the area of thin membranous CD45 signal. Scale
bars: 50 μm (column 1); 20 μm (columns 2–5); 10 μm (insets). (D) Representative high-resolution confocal microscopy images of CLK and fibrotic UUO kidneys from B6.SJL (CD45.1) mice costained for PDGFRβ and CD45. All data represent mean ± SD; n = 6. Small arrows indicate the area of thin membranous
CD45 and PDGFRβ signal in the tdTomato+ cell. Scale bars: 50 μm (column 1); 20 μm (columns 2–5).

chemokines and interleukins with markedly lower or absent expression of extracellular matrix components compared with the population of resident myofibroblasts (Figure 5J). These data indicate that
circulating PDGFRβ+CD45+ cells only contributed a minor fraction to the myofibroblast pool but might
regulate kidney fibrosis in a paracrine fashion by secretion of proinflammatory and profibrotic chemokines. We hypothesized therefore that circulating PDGFRβ+CD45+ cells might interact with resident
PDGFRβ+CD45– cells and looked into receptor-ligand interactions between the 2 cell populations within
the scRNA-seq data set. Interestingly, we observed strong expression of multiple receptor-ligand pairs
insight.jci.org   https://doi.org/10.1172/jci.insight.99561
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Figure 5. Single-cell RNA sequencing reveals that the majority of kidney myofibroblasts is derived from resident pericytes, while a small fraction
is derived from circulation. (A) Single-cell RNA sequencing was performed on PDGFRβ+CD45– cells (myofibroblasts derived from circulation) and
PDGFRβ+CD45+ cells (all other myofibroblasts) of whole fibrotic (unilateral ureteral obstruction [UUO]) kidneys. Kidneys were pooled from 3 mice, and
two 96-well plates were sorted from each population. tSNE analysis clusters 2 distinct cell populations congruent with the sorted populations. (B–I)
Expression levels of genes that define myofibroblasts, pericytes, or macrophages in both tSNE clusters (α-smooth muscle actin [Acta2]; collagen
1 α 1 [Col1a1]; collagen 3 α 1 [Col3a1]). Color key denotes the Z-score normalized average expression value of selected differentially expressed genes
between PDGFRβ+CD45– and PDGFRβ+CD45+ cells. (J) Expression levels of extracellular matrix components and proinflammatory, profibrotic cytokines
and growth factors between the 2 cell populations. (K) Ligand-receptor pair expression according to cell type. Ligands are indicated on the right,
receptors on the left. Lines indicate ligand-receptor pairs. Color key denotes the Z-score normalized average expression value.

between both cell populations (Figure 5K). Among the observed ligands, we found CXCL4/PF4 expression in the circulating cells (PDGFRβ+CD45–), and we have recently reported that CXCL4 can induce
myofibroblast differentiation in Gli1+ bone marrow cells (28). These data suggested that the circulating
population might be involved in activation and myofibroblast differentiation of the resident population
of myofibroblast precursors. We also checked the relative proliferative state of the 2 populations based on
the scRNA-seq data indicating that both populations have a high percentage of cells in the G2/M and S
phase of the cell cycle and, thus, are cells that show a proliferative response to kidney injury (Figure 6A)
insight.jci.org   https://doi.org/10.1172/jci.insight.99561
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Figure 6. Single-cell RNA sequencing data identify circulating myofibroblast progenitors as monocytes. (A) Proliferative state in the 2 cell clusters based on
gene expression. (B and C) Transcription factor (TF) activity network based on mRNA expression of TF target genes in the 2 cell populations. (D) Comparison
of both cell populations with a Drop-Seq data set (10× genomics) of human peripheral blood mononuclear cells (n = 33,000 cells, healthy donor). The color key
denotes the Pearson’s correlation coefficient (rho) between mouse and human cells. Rho has a value between –1 and 1. A greater rho value indicates higher
correlation between the two cell types.

The circulating myofibroblasts are of monocyte origin. Since transcription factors (TFs) drive cell identity,
we next estimated TF activity based on their target gene (TG) expression in the scRNA-seq data. We
aimed to identify key TFs that would define the 2 cell populations (Figure 6, B and C, and Supplemental
Tables 1 and 2). The data showed 2 entirely distinct landscapes of TF activity in the 2 cell populations,
further indicating that the 2 cell populations of resident (PDGFRβ+CD45–) and circulating myofibroblasts
(PDGFRβ+CD45+) are distinct from each other. In line with their expression of proinflammatory cytokines and their hematopoietic origin from circulation, the analysis revealed TFs that have been reported
to be critical in the inflammatory response and macrophage activation, such as ATF3 (29), Fos (30), Jun/
Junb (31), Maf (32) and EGR1 (33) among others, were central in the landscape of TF activity of the
PDGFRβ+CD45+ population (Figure 6, A and B, and Supplemental Table 1).
insight.jci.org   https://doi.org/10.1172/jci.insight.99561
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In contrast, the resident population of myofibroblasts (PDGFRβ+CD45–) was characterized by TFs
that have been reported to define tissue-resident cardiac fibroblasts/myofibroblasts, such as Tcf21 (34),
or MSCs, such as Prrx1 or Hoxd10 (35–37). Furthermore, the data suggested high activity of the nuclear
receptor subfamily 2 group member 2 (Nr2f2) in the resident PDGFRβ+CD45– population. Nr2f2 is an
important inhibitor of adipogenesis and has been recently reported to be highly expressed in Gremlin 1+
bone marrow MSCs (38). These findings are in line with our previously reported fate-tracing experiments
that found that kidney Gli1+ pericytes represent a population of MSCs and are a major source of myofibroblasts (4). We have further reported that Hedgehog/Gli signaling is a critical regulator of Gli1+ cell
expansion and that inhibition of Gli proteins is a therapeutic strategy in kidney fibrosis (39). Consistent
with these observations, the Hh pathway member and transcriptional repressor of Hh signaling, Glis2, was
among other TFs enriched in the PDGFRβ+CD45– population.
Gene ontology analysis revealed that genes involved in extracellular matrix formation, collagen production, metabolism, and growth factor binding were substantially overrepresented in the resident myofibroblast population (PDGFRβ+CD45–), reflecting their major contribution to fibrosis formation (Supplemental Figure 3A). The circulating myofibroblast population of PDGFRβ+CD45+ cells mostly showed
expression of genes that were associated with the immune response mechanism, reflecting their mechanism
of activation and homing to the injured kidney (Supplemental Figure 3).
We next asked which circulating blood population might give rise to the small kidney PDGFRβ+CD45+
myofibroblast population. We compared a published data set of human peripheral blood mononuclear cells
(PBMCs) to the resident (PDGFRβ+CD45–) and circulating (PDGFRβ+CD45+) kidney myofibroblast data
set (Figure 6D). Importantly, we did not observe any overlap of the PBMCs with the resident kidney myofibroblast population, whereas the circulating myofibroblast population of PDGFRβ+CD45+ cells correlated
strongly with human monocytes (Figure 6D). Altogether, these data indicate that circulating monocytes
contribute a minor population of myofibroblasts; while they do not secrete much extracellular matrix,
they produce high amounts of proinflammatory cytokines that might activate resident myofibroblasts. We
next asked whether the circulating myofibroblast population of PDGFRβ+CD45+ cells shows expression of
genes that have been reported to characterize M1 or M2 macrophages. Interestingly, PDGFRβ+CD45+ cells
primarily showed expression of classically activated, proinflammatory M1 macrophages, such as Socs3,
Tlr2, Il1b, TNFa, Ccl2, and Ccl8 (Supplemental Figure 3B).

Discussion
Our data indicate that proximal tubular epithelium does not contribute to the myofibroblast pool, whereas
circulating monocytes contribute a minor population of αSMA+ myofibroblasts. A contribution of monocytes and macrophages to the myofibroblast pool has been described by several groups (18, 23, 24, 40).
However, Reich et al. have reported that fibrocytes independent of monocyte lineages are an important
source of kidney myofibroblasts (17). As macrophages are a major site of collagen internalization and
degradation, antibody staining for matrix proteins might be difficult to interpret (2). Importantly, there is
an ongoing debate as to whether there is a direct contribution of myeloid leukocytes to the myofibroblast
pool at all, and many reported effects might have been results of indirect mechanisms (2, 41). Indeed, in
this work, we show, using two powerful and complementary approaches, that a small percentage of kidney myofibroblasts derive from monocytes. However, importantly, these myeloid-derived myofibroblasts
express very few matrix genes — suggesting they do not play a direct role in interstitial matrix accumulation. The data indicate that PDGFRβ+CD45+ monocytes primarily secrete high amounts of proinflammatory profibrotic cytokines that have been reported to activate resident myofibroblasts, suggesting paracrine communications between circulating monocytes and resident myofibroblasts driving fibrosis as well.
Thus, the direct contribution of circulating monocytes to the myofibroblast pool and matrix production is
minor compared with their paracrine effects. This scRNA-seq data set confirms that the great majority of
kidney myofibroblasts are of resident kidney origin.
A contribution of circulating bone marrow MSCs to the kidney myofibroblast pool has been discussed
for several years as well (11). After parabiosis, two mice share one blood circulation, which allows rapid
exchange of blood, cells, and particles, such as ultrasound bubbles, from one mouse to the other independent of cell size (42, 43). Therefore, our parabiosis approach, with induced labeling of all cells (90% recombination efficiency) in one mouse and induction of kidney fibrosis in the other mouse, allows quantitative
tracking of all circulating cells, which would in theory also include MSCs. However, we found, through
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two independent experiments, that only CD45+ and thus hematopoietic (nonmesenchymal) cells contribute
a small population of myofibroblast. Of note, CD45 expression is an exclusion criterion for MSCs.
First, the parabiosis experiments demonstrate that circulating tdTomato+ cells in blood, spleen, and
kidney are all CD45+, and all of the circulating myofibroblasts we observed (tdTomato+/αSMA+) in the
UUO kidneys also showed coexpression of CD45. However, in the parabiosis experiments, our recombination efficiency was 90%, and, thus, although unlikely, we can not exclude that among the nonlabeled cells
some nonhematopoietic cells might have contributed to the myofibroblast pool.
Second, since we have previously reported that all kidney myofibroblasts express PDGFRβ (4, 13), we
performed nonbiased scRNA-seq of PDGFRβ+ cells that were either CD45+ (hematopoietic) or CD45–
(nonhematopoietic) to profile all kidney myofibroblasts. The data indicate that the vast majority of kidney
myofibroblasts are of resident origin, while a minor fraction of circulating hematopoietic (CD45+) cells also
expressed the myofibroblast marker αSMA. Importantly, when comparing the data set to a human PBMC
scRNA-seq data set, only the circulating (PDGFRβ+CD45+) population showed a strong correlation, and
the comparison identified monocytes as the origin of circulating myofibroblasts. Thus, our data indicate
that circulating MSCs do not contribute to the myofibroblast pool.
Importantly, we have also recently reported bone marrow transplantation and parabiosis experiments,
indicating that Gli1+ MSCs do not circulate (4), and a recent study reports no evidence for circulating
MSCs in patients with organ injury, unless they suffer severe trauma with multiple fractures, which leads to
mechanical disruption of bone marrow with embolism (44). However, the scRNA-seq experiment was not
performed as a time course, and thus we cannot account for dynamic changes in expression of the markers
over the course of the experiment.
In conclusion, kidney myofibroblasts arise primarily from resident mesenchymal cells, whereas circulating monocytes contribute a minor fraction. Importantly, these circulating myofibroblasts primarily
secrete proinflammatory cytokines and do not appreciably contribute to extracellular matrix production.

Methods
Mice
Rosa26CreERt2 (JAX 008463), Rosa26tdTomato (JAX 007909), B6-CD45.1 (JAX 002014), and C57BL/6J
(JAX 000664) mice were purchased from Jackson Laboratories. In the parabiosis experiment, bigenic Rosa26CreER;tdTomato mice (females, 8 weeks of age) received tamoxifen (4 × 10 mg in corn oil with 3% ethanol ) per oral gavage (every other day) and were conjoined with B6-CD45.1 mice (8-week-old females) 10
days after the last tamoxifen dose. Parabiosis was performed as previously described (45, 46).
Anesthesia was achieved by intraperitoneal injection of ketamine (100 mg/kg bodyweight), xylazine
(10 mg/kg), and acepromazine (3 mg/kg). Buprenorphine (0.05 mg/kg), meloxicam (1 mg/kg), and lidocaine (1%) were given subcutaneously to achieve analgesia.
The entire flank of each mouse was shaved, and the skin was cleaned with triple applications of a
povidone-iodine soap, alternating with an alcohol rinse. Thereafter, matching skin incisions were made
from the elbow to the knee joint of each mouse. The right olecranon of one animal was attached to the left
olecranon of the other by a single 4-0 suture and tie. Similarly, the partners’ knee joints were connected.
The dorsal and ventral skin was then anastomosed by staples and suture. Four weeks after parabiosis, surgery blood was drawn from the retro-orbital vein plexus to check cross-circulation efficiency. Thereafter,
the B6-CD45.1 mice underwent UUO surgery as follows. Anesthesia and analgesia was achieved in the
parabiosis pair as described above. After flank incision, the right kidney was exposed and freed from the
perirenal fat tissue and the ureter was tied off at the level of the lower pole using two 4.0 silk ties. Wounds
were closed by staples. Mice were sacrificed at 10 days after UUO surgery. UUO surgeries in C57BL/6
wild-type mice were performed at 8 weeks of age using the same technique.

Tissue preparation and histology
Mice were anesthetized with isofluorane (Baxter) and subsequently perfused via the left ventricle with 4°C
PBS for 1 minute. For histological analyses, tissue sections were fixed in 10% formaldehyde for 1 hour, paraffin embedded, cut with a rotating microtome at a thickness of 3 μm, and stained according to routine histological protocols. For immunofluorescence studies, kidneys were fixed in 4% paraformaldehyde on ice for 1 hour
and then incubated in 30% sucrose in PBS at 4°C overnight. OCT-embedded (Sakura FineTek) tissues were
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cryosectioned into 5-μm sections and mounted on Superfrost slides (Fisher Scientific). Sections were washed
in 1× PBS, blocked in 10% normal goat serum (Vector Labs), and incubated with primary antibodies specific
for α-SMA-FITC (mouse, 1:100, MilliporeSigma, catalog F3777), PDGFRb (rabbit, 1:100, Abcam, catalog
ab32570), and CD45 (rat, 1:100, Novusbio, NB100-77417). Secondary antibodies were FITC- or Cy5-conjugated (Jackson ImmunoResearch). Sections were then stained with DAPI and mounted in Prolong Gold (Life
Technologies). All images were obtained by confocal (Zeiss LSM880, equipped with an Airyscan detector)
through the Washington University Center for Cellular Imaging. Fibrosis was scored at ×400 magnification
using a counting grid with 117 intersections. The number of grid intersections overlying trichrome-positive
interstitial areas was counted and expressed as a percentage of all grid intersections. Intersections that were in
tubular lumen and glomeruli were subtracted from the total number of grid intersections.

Flow cytometry and cell sorting
For flow cytometric analysis or FACS, mice were euthanized as described above and perfused with sterile
PBS via the left ventricle, and the kidneys were placed in PBS with 5% FBS. After thoroughly mincing
the tissue/organ using a sterile scalpel (Feather), the tissue/organ was placed in gentleMACS C Tubes
(Miltenyi Biotec) containing 1.5 ml DMEM (Life Technologies) with 0.1 mg/ml Liberase TL (Roche). The
tissue was then dissociated using the D program of the gentleMacs dissociator (Miltenyi Biotec) followed
by 30 minutes incubation at 37°C. Following washing steps with FACS buffer and centrifugation (300 g,
5 minutes), the solution was filtered twice through a 40-μm cell strainer (BD Biosciences) and transfered
to 5-ml Polystyrene Round-Bottom FACS tube (BD Biosciences). For flow cytometric studies, the samples
were stained in 100–500 μl FACS buffer using the following fluorochrome-conjugated antibodies: CD45.1
(APC-Cy7, ebioscience, 25045382), CD45.2-FITC (ebioscience, 110454), α-SMA-FITC (MilliporeSigma, F3777), PDGFRb-APC (Biolegend, 136008), and CD45-BV421 (Biolegend, 103133) all 1:100 for 30
minutes followed by a washing step with PBS. Cytofix/Cytoperm solution (BD Biosciences) was used to
achieve staining for intracellular α-SMA. All flow cytometric analyses were performed with a Canto II
analyzer (BD Biosciences). For sorting, DAPI (1 mg/ml, 1:1,000) was added in order to exclude dead cells.
Single-cell sorting was performed at the Siteman Flow Cytometry Core (Washington University in St. Louis) using an iCyt Synergy sorter (Sony). Single cells were sorted directly into 10× lysis buffer (Clontech) in
96-well PCR plates. Data were analyzed by using Flow Jo software (version 9.6.2, Tree Star Inc.).

Single-cell RNA-sequencing and data preprocessing
96-well plates with single cell in each well were sealed and sent to the sequencing core at Washington
University in St. Louis (Genome Technology Access Center). RNA from individual wells was processed
with the Clonetech Smarter system and ligated with unique barcodes. Each plate was then pooled into one
library, and the resulting pools were then ligated to adapters containing unique 7-bp index sequences, so
that samples originating from a single plate can be identified by Illumina conventional indexing strategies
and each individual well is defined by barcodes sequenced on the first read of a paired end read pair.
All plates were pooled into a single library and subjected to Illumina sequencing (HiSeq2500, 2 × 50 bp).
The resulting sequencing reads were demultiplexed by index with a custom Phython demultiplexing script
and further demultiplexed by barcode with a custom Perl demultiplexing script. The RNA-sequencing reads
were then aligned to the Mus musculus Ensembl release 76 top-level assembly with STAR version 3.0.4.b.
Gene counts were derived from the number of uniquely aligned unambiguous reads by Subread:featureCount version 1.4.5. Sailfish version 0.6.3 was used to produce isoform estimated counts. Gene and isoform
counts were further transformed into counts per million (CPM), using log2 CPM with a prior count of 2
(moderated log2CPM), and RPKM with custom Rscripts. Sequencing performance was assessed for the total
number of aligned reads, the total number of uniquely aligned reads, the genes and transcripts detected, the
ribosomal fraction, the known junction saturation, and the read distribution over known gene models with
RSeQC version 2.3. The single-cell RNA-sequencing raw data are available in the Gene Expression Omnibus database (accession GSE112033).

Bioinformatics
Unsupervised clustering and differential gene analysis. We used Seurat software in R to identify cell clusters,
performed differential gene analysis, and generated the top gene heatmap. In brief, a gene expression matrix
with gene names as rows and cell names as columns was input into Seurat. Before clustering, we removed
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genes with low expression levels and low-quality cells by filtering out genes that were expressed in less than
10 cells and cells that had a greater than 20% mitochondrial gene content, resulting in 14,062 genes and
357 cells. After filtering, we normalized the expression values for each cell by the total expression, multiplied this by 10,000, and log transformed the result. Next, we performed dimensionality reduction on the
scaled data by computing the significant principal components (PCs) on highly variable genes. Graph-based
clustering analyses were performed on the first 10 PCs, and clusters were visualized in tSNE. To examine
potential batch effect, cells were colored by plates and plotted in the same tSNE. Differential gene analysis
was performed using the FindAllMarkers function in Seurat (likelihood-ratio test). Differentially expressed
genes that were expressed at least in 25% cells within the cluster and with a fold change of more than 0.25
(log scale) were considered to be marker genes. Marker genes in each cluster were visualized by two different ways: we used the DoHeatmap function (Seurat) to show the top 30 genes for each cluster and the FeaturePlot function (Seurat) to plot the well-known markers. To compare the relative expression of profibrotic
genes and proinflammatory genes between clusters, we selected genes that are components of extracellular
matrix and genes that are known as cytokines/chemokines from the differential gene list. The average
expression level of these selected genes was Z-score normalized and visualized using the pheatmap package
in R. To classify the gene function of the marker genes, we uploaded the differential gene list onto ToppGene suite (https://toppgene.cchmc.org) for gene set functional enrichment analysis. The top 5 enriched
gene ontology terms from each category (molecular function, cellular components, and biological function)
were compared among clusters, and bar graphs shown in figures were generated using the ggplot2 package.
Comparison of fibrocytes and a public PBMC data set. Cell-type–specific expression patterns of the cell
clusters identified in our data set were compared with signatures previously defined in a PBMC data
set by calculating the pairwise Pearson correlations coefficients between each pair of cell types for the
same set of genes. First, a precomputed Seurat object containing cell cluster information for 33,000
human PBMCs was downloaded from Satija Lab (http://satijalab.org/seurat/get_started.html). Second, mouse genes were converted to human equivalent genes using a R package biomaRt. Only genes
that are detected in our data set and the PBMC data set were used for downstream correlation analysis.
Third, Pearson correlation was computed between the cell clusters in our data set and the cell clusters
identified in the PBMC data set, using the previously defined cell-type annotations and normalized
average gene expression values for each cell type. Data were shown by pheatmap R package.
Construction of transcription network by driving force analysis. To identify the key regulators that control the
cell states, we established the relationship between TFs and their TGs following the SINCERA pipeline (47).
This approach consists of three main steps. First, the candidate TFs and TGs were extracted from the DEG
list identified in each cluster. Second, cell-type–specific transcription regulatory network (TRN) was constructed by establishing the interaction between TF-TF and TF-TG as previously described (48). TG-TF and
TF autoregulations were not considered in the present study. Finally, the key TFs were selected based on their
network node importance and ranked by integrating 6 node importance metrics, including degree centrality,
closeness centrality, betweenness centrality, disruptive fragmentation centrality, disruptive connection centrality, and disruptive distance centrality. The TRN igraph object obtained from SINCERA was converted to
JSON using a R package RJSONIO and imported into Cytoscape (version 3.4.0) for network visualization.

Ligand-receptor interaction analysis
To study ligand-receptor interactions between myofibroblast and fibrocyte, we used a human ligand-receptor list comprising 2,557 ligand-receptor pairs curated by the Database of Ligand-Recetor Partners,
IUPHAR, and Human Plasma Membrane Receptome (49). We selected the receptors that were only differentially expressed in each cell type. To determine the ligand-receptor pairs to plot on the heatmap, we
required that (a) the receptors are uniquely expressed in each cell type (q < 0.05 and log fold change > 0.6)
and (b) each receptor should have at least one corresponding ligand to pair with. We used heatmap.2 function from gplots package to visualize the ligand-receptor pairs.

Statistics
Data are presented as mean ± SD. Comparison of two groups was performed using unpaired 2-tailed t
test. Paired 2-tailed t test was used for comparison of repeated measured in the same group. Statistical
analyses were performed using GraphPad Prism 5.0c (GraphPad Software Inc.). A P value of less than
0.05 was considered significant.
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